BIOMARIN PHARMACEUTICAL INC revenue breakdown overview

BIOMARIN PHARMACEUTICAL INC revenue for the last year amounted to 2.76 B EUR, the most of which — 2.76 B EUR — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 2.19 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought BIOMARIN PHARMACEUTICAL INC 893.35 M EUR, and the year before that — 698.82 M EUR.